BMSSC
REGN icon

B. Metzler seel. Sohn & Co’s Regeneron Pharmaceuticals REGN Stock Holding History

B. Metzler seel. Sohn & Co’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.51M Sell
3,252
-37
-1% -$28.3K 0.02% 338
2025
Q4 		$2.54M Buy
3,289
+64
+2% +$43.5K 0.02% 348
2025
Q3 		$1.81M Hold
3,225
– – 0.02% 413
2025
Q2 		$1.69M Hold
3,225
– – 0.02% 417
2025
Q1 		$2.05M Sell
3,225
-135
-4% -$92.9K 0.02% 354
2024
Q4 		$2.39M Hold
3,360
– – 0.02% 334
2024
Q3 		$3.53M Sell
3,360
-578
-15% -$643K 0.04% 267
2024
Q2 		$4.14M Buy
3,938
+109
+3% +$106K 0.04% 221
2024
Q1 		$3.69M Buy
3,829
+219
+6% +$208K 0.04% 247
2023
Q4 		$3.17M Sell
3,610
-2,368
-40% -$1.95M 0.04% 258
2023
Q3 		$4.92M Buy
5,978
+545
+10% +$428K 0.07% 164
2023
Q2 		$3.9M Sell
5,433
-536
-9% -$413K 0.05% 245
2023
Q1 		$4.9M Sell
5,969
-2,104
-26% -$1.59M 0.08% 156
2022
Q4 		$5.83M Sell
8,073
-67
-0.8% -$49.4K 0.1% 140
2022
Q3 		$5.61M Buy
8,140
+184
+2% +$116K 0.1% 142
2022
Q2 		$4.7M Buy
7,956
+443
+6% +$288K 0.08% 172
2022
Q1 		$5.25M Buy
7,513
+968
+15% +$612K 0.07% 178
2021
Q4 		$4.21M Sell
6,545
-1,080
-14% -$664K 0.05% 216
2021
Q3 		$4.61M Sell
7,625
-77
-1% -$47.8K 0.07% 175
2021
Q2 		$4.3M Buy
7,702
+361
+5% +$183K 0.06% 169
2021
Q1 		$3.47M Buy
+7,341
New +$3.57M 0.06% 201

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

B. Metzler seel. Sohn & Co's REGN Position: Q1 2026 in Review

B. Metzler seel. Sohn & Co reduced its Regeneron Pharmaceuticals (REGN) stake by 1.1% in Q1 2026, selling an estimated $28.3K and leaving 3,252 shares worth $2.51M. The position accounts for 0.02% of the portfolio, ranked #338.

B. Metzler seel. Sohn & Co first reported a position in REGN in Q1 2021 and has held it in 21 quarters since. The position peaked at $5.83M in Q4 2022. 1,396 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • B. Metzler seel. Sohn & Co held 3,252 shares of Regeneron Pharmaceuticals worth $2.51M as of Q1 2026.
  • B. Metzler seel. Sohn & Co sold 37 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $28.3K.
  • Regeneron Pharmaceuticals made up 0.02% of B. Metzler seel. Sohn & Co's portfolio in Q1 2026, its #338 holding.
  • B. Metzler seel. Sohn & Co first reported a position in Regeneron Pharmaceuticals in Q1 2021 and has held it in 21 quarters since.
  • B. Metzler seel. Sohn & Co's Regeneron Pharmaceuticals position peaked at $5.83M in Q4 2022.
  • 1,396 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on B. Metzler seel. Sohn & Co's 13F filing for Q1 2026, filed 8 May 2026.